Brief: Aptevo Therapeutics Reports Qtrly Loss Per Share of $1.43
Nov 12 (Reuters) - Aptevo Therapeutics Inc APVO.O :
* APTEVO THERAPEUTICS INC - QTRLY LOSS PER SHARE OF $1.43
* APTEVO THERAPEUTICS INC - RESTRICTED CASH OF $1.3 MILLION
AS OF
SEPTEMBER 30, 2021 IS EXPECTED TO BE RELEASED OVER NEXT TWELVE
MONTHS
Further company coverage: APVO.O
(Reporting by Nandhini Srinivasan)
((Nandhini.Srinivasan@thomsonreuters.com;))
Recent news on Aptevo Therapeutics
See all newsBrief: Aptevo Therapeutics - Enters Amendment No. 6 To Rights Agreement On October 23, 2026 - SEC Filing
U.S. STOCKS ON THE MOVE-Principal Financial Group, NetApp
U.S. STOCKS ON THE MOVE-Genesco, Fervo Energy, Tyson Foods
Aptevo Therapeutics reports early data for blood cancer therapy; shares fall
Aptevo Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary